TY - JOUR
T1 - Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis
AU - Tsitsou-Kampeli, Afroditi
AU - Suzzi, Stefano
AU - Kenigsbuch, Mor
AU - Satomi, Akisawa
AU - Strobelt, Romano
AU - Singer, Oded
AU - Feldmesser, Ester
AU - Purnapatre, Maitreyee
AU - Colaiuta, Sarah Phoebeluc
AU - David, Eyal
AU - Cahalon, Liora
AU - Hahn, Oliver
AU - Wyss-Coray, Tony
AU - Shaul, Yosef
AU - Amit, Ido
AU - Schwartz, Michal
N1 - Publisher Copyright: © 2023 The Author(s)
PY - 2023/11/21
Y1 - 2023/11/21
N2 - The choroid plexus (CP) plays a key role in remotely controlling brain function in health, aging, and disease. Here, we report that CP epithelial cells express the brain-specific cholesterol 24-hydroxylase (CYP46A1) and that its levels are decreased under different mouse and human brain conditions, including amyloidosis, aging, and SARS-CoV-2 infection. Using primary mouse CP cell cultures, we demonstrate that the enzymatic product of CYP46A1, 24(S)-hydroxycholesterol, downregulates inflammatory transcriptomic signatures within the CP, found here to be elevated across multiple neurological conditions. In vitro, the pro-inflammatory cytokine tumor necrosis factor α (TNF-α) downregulates CYP46A1 expression, while overexpression of CYP46A1 or its pharmacological activation in mouse CP organ cultures increases resilience to TNF-α. In vivo, overexpression of CYP46A1 in the CP in transgenic mice with amyloidosis is associated with better cognitive performance and decreased brain inflammation. Our findings suggest that CYP46A1 expression in the CP impacts the role of this niche as a guardian of brain immune homeostasis.
AB - The choroid plexus (CP) plays a key role in remotely controlling brain function in health, aging, and disease. Here, we report that CP epithelial cells express the brain-specific cholesterol 24-hydroxylase (CYP46A1) and that its levels are decreased under different mouse and human brain conditions, including amyloidosis, aging, and SARS-CoV-2 infection. Using primary mouse CP cell cultures, we demonstrate that the enzymatic product of CYP46A1, 24(S)-hydroxycholesterol, downregulates inflammatory transcriptomic signatures within the CP, found here to be elevated across multiple neurological conditions. In vitro, the pro-inflammatory cytokine tumor necrosis factor α (TNF-α) downregulates CYP46A1 expression, while overexpression of CYP46A1 or its pharmacological activation in mouse CP organ cultures increases resilience to TNF-α. In vivo, overexpression of CYP46A1 in the CP in transgenic mice with amyloidosis is associated with better cognitive performance and decreased brain inflammation. Our findings suggest that CYP46A1 expression in the CP impacts the role of this niche as a guardian of brain immune homeostasis.
UR - http://www.scopus.com/inward/record.url?scp=85177857372&partnerID=8YFLogxK
U2 - 10.1016/j.xcrm.2023.101278
DO - 10.1016/j.xcrm.2023.101278
M3 - مقالة
C2 - 37944529
SN - 2666-3791
VL - 4
JO - Cell Reports Medicine
JF - Cell Reports Medicine
IS - 11
M1 - 101278
ER -